Similar Articles
371 Effects of SARS-CoV-2 infection on incidence and treatment strategies of hepatocellular carcinoma in people with chronic liver disease
372 Actuality and underlying mechanisms of systemic immune-inflammation index and geriatric nutritional risk index prognostic value in hepatocellular carcinoma
373 Systemic inflammatory response index is a predictor of prognosis in gastric cancer patients: Retrospective cohort and meta-analysis
374 Comparative effectiveness of several adjuvant therapies after hepatectomy for hepatocellular carcinoma patients with microvascular invasion
375 Efficacy and safety of remimazolam in bronchoscopic sedation: A meta-analysis
376 Identification of immune cell-related prognostic genes characterized by a distinct microenvironment in hepatocellular carcinoma
377 From prediction to prevention: Machine learning revolutionizes hepatocellular carcinoma recurrence monitoring
378 Meta-analysis of factors influencing anterior knee pain after total knee arthroplasty
379 Progress in the treatment of advanced hepatocellular carcinoma with immune combination therapy
380 Prognostic value of circulating tumor cells combined with neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA